<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Consensus Statements Developed for Rheumatoid Arthritis-Linked Interstitial Lung Disease

minute read

by HealthDay | July 14, 2026
placeholder

Consensus statements have been developed for screening, diagnosis, and treatment of rheumatoid arthritis-associated interstitial lung disease (ILD); the statements were published online June 5 in The Lancet Respiratory Medicine.

Topics: Press Coverage